Results 201 to 210 of about 575,729 (357)

Case Report: TFE3 Positive Xp11.2 Translocation Renal Cell Carcinoma (TRCC) – A Case Study and Review of the Literature

, 2022
Ignacy Miroński, Jan Mateusz Zaucha, Jacek Kowalski, Renata Zaucha   +3 more
openalex   +1 more source

Integrin β3 Orchestrates Hepatic Steatosis via a Novel CD36‐Dependent Lipid Uptake Complex

Advanced Science, EarlyView.
In MASH, ITGB3 recruits LYN and drives its ubiquitin‐proteasomal degradation via phosphorylation. This relieves DHHC5 inhibition, enabling ITGB3/DHHC5/CD36 complex assembly to enhance CD36 palmitoylation and fatty acid uptake, thereby exacerbating disease. Targeting ITGB3 blocks this pathogenic axis and ameliorates MASH.
Ying Zhang, Lei Dai, Zhongquan Cui, Ye Zhou, Wenyuan Dong, Hongcheng Jiang, Mengwen Wang, Xiaodan Zhong, Wei Dong, Zhang Yue, Thati Madhusudhan, Hongjie Wang, Xiong Zhong Ruan, Hesong Zeng   +13 more
wiley   +1 more source

A Rare Case of Renal Cell Carcinoma Metastasis to the Coracoid Process. [PDF]

Cureus
Patel M, Deshpande A.
europepmc   +1 more source

Galectin‐3 promotes CXCR2 to augment the stem‐like property of renal cell carcinoma [PDF]

, 2018
Chang‐Shuo Huang, Shye‐Jye Tang, Mei‐Hsuan Lee, C Wang, Guang‐Huan Sun, Kuang‐Hui Sun   +5 more
openalex   +1 more source

Thermally Gated Dual‐Cascade Nanozyme for Enhanced Mild‐Temperature Photothermal Therapy

Advanced Science, EarlyView.
A thermo‐responsive cascade nanozyme (Ru‐GOx‐PNN) synergistically enhances mild photothermal therapy by dual suppression of HSP70 through ROS‐induced lipid peroxidation and ATP depletion. This intelligent system effectively overcomes thermotolerance and amplifies apoptosis, offering a safe and precise strategy for tumor treatment.
Shuyu Wang, Shenghui Wang, Mengyuan Cao, Lulu Wang, Wei Jiang, Xiyun Yan, Ying Liu, Bing Jiang   +7 more
wiley   +1 more source

Clinical and Molecular Characterization of KRAS-Mutated Renal Cell Carcinoma. [PDF]

Cancers (Basel)
Lopez Sanmiguel A, Khandwala YS, Fengshen K, Dawidek M, Tse E, Barbakoff D, Posada Calderon L, Carlo MI, Coleman J, Russo P, Tickoo SK, Reuter VE, Reznik E, Chen YB, Hakimi AA.   +14 more
europepmc   +1 more source

MR‐DELTAnet: A Longitudinal MRI‐Transformer Model Predicting Pathological Complete Response and Revealing Immune Microenvironment via scRNA‐seq in Locally Advanced Rectal Cancer

Advanced Science, EarlyView.
The MR‐DELTAnet model utilizes longitudinal MRI to predict treatment response after neoadjuvant chemoradiotherapy in locally rectal cancer patients, accurately identifying patients likely to achieve pathological complete response for personalized management.
Wuteng Cao, Huaxian Chen, Jiao Li, Yihui Zheng, Liqing Xie, Guozhong Xiao, Zeyan Wang, Fen Yuan, Junhong Chen, Chongbao Sun, Jing Dai, Jinping Zeng, Xinhua Wang, Lei Wu, Hongcheng Lin   +14 more
wiley   +1 more source

Deciphering genetic susceptibility to clear cell renal cell carcinoma. [PDF]

Commun Biol
Mandelia M, Law PJ, Mills C, Went M, Vijayakrishnan J, Houlston RS.   +5 more
europepmc   +1 more source

Biomimetic Nanomedicine for Senescence‐Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma

Advanced Science, EarlyView.
A multifunctional mPDZM nanoplatform is developed in this study. mPDZM integrates chemotherapy‐induced senescence, selective senolysis, and STING‐mediated immune activation. mPDZM effectively clears senescent tumor cells, remodels the tumor immune microenvironment, and enhances antitumor T‐cell responses.
Shiji Fang, Liyun Zheng, Bin Lin, Jiale Chen, Dehai Hou, Yiming Ding, Mengzhu Han, Pan Qin, Mengyuan Wang, Xiaoju Guo, Yeyu Zhang, Gaofeng Shu, Fazong Wu, Jianfei Tu, Minjiang Chen, Zhongwei Zhao, Zhuang Liu, Jiansong Ji   +17 more
wiley   +1 more source

Renal Cell Carcinoma with Fibromyomatous Stroma: A Case Report. [PDF]

Am J Case Rep
Keshk EM, Kashif A, Alsulaiman AS, Abdullah NA, Alafghani SO, Alzahrani HSJ, Alghamdi EM, Alhuthali RK, Alasiri KA, Alharthi RF, Alharthi RF, Barnawi HR, Alotaibi WM.   +12 more
europepmc   +1 more source